In vitro and in vivo pharmacological profile of MGS0039, a novel potent and selective antagonist of group II metabotropic glutamate receptor

被引：0
|
作者：
Yoshikawa, R
Okuno, S
Shimazaki, T
Yasuhara, A
Okuyama, S
Nakazato, A
Nakanishi, S
Chaki, S
机构：
[1] Taisho Pharmaceut Co Ltd, Med Res Labs, Saitama 3319530, Japan
[2] Taisho Pharmaceut Co Ltd, Pharmaceut Business Div, Saitama 3319530, Japan
[3] Kyoto Univ, Fac Med, Dept Biol Sci, Kyoto 6068501, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2004年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：165P / 165P
页数：1
相关论文
共 50 条
  • [1] MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity
    Chaki, S
    Yoshikawa, R
    Hirota, S
    Shimazaki, T
    Maeda, M
    Kawashima, N
    Yoshimizu, T
    Yasuhara, A
    Sakagami, K
    Okuyama, S
    Nakanishi, S
    Nakazato, A
    NEUROPHARMACOLOGY, 2004, 46 (04) : 457 - 467
  • [2] Antidepressant and anti-OCD-like activity of MGS0039, a potent and selective group II metabotropic glutamate receptor antagonist
    Shimazaki, T
    Hirota-Okuno, S
    Iijima, M
    Yoshimizu, T
    Chaki, S
    BEHAVIOURAL PHARMACOLOGY, 2004, 15 (5-6): : A26 - A26
  • [3] Anxiolytic-like activity of MGS0039, a potent group II metabotropic glutamate receptor antagonist, in a marble-burying behavior test
    Shimazaki, T
    Iijima, M
    Chaki, S
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 501 (1-3) : 121 - 125
  • [4] Effects of group II metabotropic glutamate receptor antagonist, MGS0039 in rodent tests of anxiety-like behaviour
    Stachowicz, K.
    Domin, H.
    Pilc, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S156 - S157
  • [5] Increased cell proliferation in the adult mouse hippocampus following chronic administration of group II metabotropic glutamate receptor antagonist, MGS0039
    Yoshimizu, T
    Chaki, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 315 (02) : 493 - 496
  • [6] On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039
    Agnieszka Pałucha-Poniewiera
    Joanna M. Wierońska
    Piotr Brański
    Katarzyna Stachowicz
    Shigeyuki Chaki
    Andrzej Pilc
    Psychopharmacology, 2010, 212 : 523 - 535
  • [7] On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039
    Palucha-Poniewiera, Agnieszka
    Wieronska, Joanna M.
    Branski, Piotr
    Stachowicz, Katarzyna
    Chaki, Shigeyuki
    Pilc, Andrzej
    PSYCHOPHARMACOLOGY, 2010, 212 (04) : 523 - 535
  • [8] A metabotropic glutamate 2/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell
    Karasawa, JI
    Yoshimizu, T
    Chaki, S
    NEUROSCIENCE LETTERS, 2006, 393 (2-3) : 127 - 130
  • [9] Anxiolytic-like activity of MGS0039, a selective group II mGlu receptor antagonist, is serotonin- and GABA-dependent
    Stachowicz, Katarzyna
    Wieronska, Joanna
    Domin, Helena
    Chaki, Shigeyuki
    Pilc, Andrzej
    PHARMACOLOGICAL REPORTS, 2011, 63 (04) : 880 - 887
  • [10] Anxiolytic-like activity of MGS0039, a selective group II mGlu receptor antagonist, is serotonin- and GABA-dependent
    Katarzyna Stachowicz
    Joanna Wierońska
    Helena Domin
    Shigeyuki Chaki
    Andrzej Pilc
    Pharmacological Reports, 2011, 63 : 880 - 887
12345